# Continuous Fascia Iliaca Block for Acute Hip Fractures

> **NCT03588689** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 30 (actual)

## Conditions studied

- Hip Fractures
- Neuromuscular Blockade
- Respiratory Morbidity
- Delirium
- Fascia Iliaca Block
- Pain

## Interventions

- **PROCEDURE:** Continuous fascia iliaca block
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT03588689
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-07
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-05-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03588689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03588689, "Continuous Fascia Iliaca Block for Acute Hip Fractures". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03588689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*